Ledger.Open graph →
SEC Form D · filed November 8, 2018

Phosplatin Therapeutics LLC

Offering
$16.6M
Sold
$16.6M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
NEW YORK, NY
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (14)

Frances Bonham · NEW YORK, NYExecRobert Fallon · NEW YORK, NYExec · DirectorMatthew Price · NEW YORK, NYExec · DirectorPeter Espig · VANCOUVER, British Columbia, CanadaDirectorJohn Caouette · NEW YORK, NYDirectorRosita Leong · NEW YORK, NYDirectorJohn Porter · East Amherst, NYDirectorFrances Bonham · NEW YORK, NYExecRobert Fallon · NEW YORK, NYExec · DirectorMatthew Price · NEW YORK, NYExec · DirectorPeter Espig · NEW YORK, NYDirectorJohn Caouette · NEW YORK, NYDirectorRosita Leong · NEW YORK, NYDirectorJohn Porter · NEW YORK, NYDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗